John K. Waas

John Waas practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

John Waas' NPI, 1093789489, was assigned on February 14, 2006. John Waas graduated from Philadelphia College of Osteopathic Medicine in 1996. John Waas holds Pennsylvania license OS009615L.

John Waas' primary practice is UPMC Magee-Womens Hospital, at 300 Halket Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 641-4010.

John Waas' primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. John Waas is also affiliated with Westmoreland Hospital. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links John Waas to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Waas practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is John Waas' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. John Waas is licensed in Pennsylvania.

CMS data shows 200 Medicare services from John Waas across 5 procedure codes in 2024, for 98 Medicare patients. Medicare paid $5,152 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw John Waas in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John Waas' median patient age at 74, with 66% women.

In 2024, John Waas wrote 93 Medicare Part D claims for 41 patients. 57% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $212,957 in total drug cost. In 2023, CMS named 412 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 64 out of 100 for John Waas for performance year 2024, reported as part of a group. John Waas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to John Waas, published from 2012 to 2024. John Waas' most frequent co-authors are Mounzer E. Agha, MD, Jonathan Edwards Dowell, MD and Jason C. Fleming, MD.

Dmand AI links John Waas to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 81 general payments to John Waas from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $935.

John Waas graduated from Philadelphia College of Osteopathic Medicine in 1996.